SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Retained Earnings
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Retained Earnings of -$51.60 million as of 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-09-24
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$51.60M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$48.45M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$46.30M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$43.68M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$51.60M 10-Q · filed 2026-09-24 | |
| 2026-03-31 | -$48.45M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$46.30M 10-Q · filed 2026-09-24 | |
| 2025-09-30 | -$43.68M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$41.34M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$37.63M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$34.58M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$32.98M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$29.20M 10-Q · filed 2024-09-04 | |
| 2024-03-31 | -$27.16M 10-Q/A · filed 2024-09-04 | -$17.22M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$25.43M 10-K · filed 2025-02-26 | -$15.49M 10-K · filed 2024-03-21 |
| 2023-09-30 | -$23.79M 10-K/A · filed 2024-09-04 | -$13.85M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$12.05M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$9.87M 10-Q · filed 2023-05-25 | |
| 2022-12-31 | -$18.84M 10-K/A · filed 2024-09-04 | -$8.89M 10-K · filed 2023-03-15 |
| 2022-09-30 | -$8.14M 10-Q · filed 2022-11-14 | |
| 2021-12-31 | -$13.84M 10-K/A · filed 2024-09-04 | -$5.80M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |